Kenya Anti-fungal Market Analysis


  • Type: Common Disease Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4843

  • Format: PPT, PDF

Kenya Antifungal Drug Market: Segmented by Drug Class (Echinocandins, Azoles, Polyenes, Allylamines, and Other Drug Classes), Route of Administration (Oral, Topical and Parenteral) and Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, and Others)- Growth, Trends, and Forecasts (2019 – 2028)

SKU: 4843 Categories: ,

Report Overview

The Antifungal drug market size in Kenya stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Antifungal drugs are used to treat fungal infections caused by a wide range of fungi. Common fungal infections prevalent among Kenyan population are Tinea capitis, Oral candidiasis, Oesophageal candidiasis, Vaginal candidiasis, Chronic Pulmonary Aspergillosis, Cryptococcal meningitis, Pneumocystis pneumonia and Fungal keratitis. The high burden of fungal infections may be attributed to opportunistic infections in HIV and TB patients. It is estimated that, at any one time, about 7% of the Kenyan population suffers from a significant fungal infection, with recurrent vaginitis and tinea capitis accounting for 82% of the infections. The antifungal drugs are available in different formulations (oral tablet, oral capsule, cream, shampoo, sterile IV solution, lotion, vaginal cream, and ointments).

Market Drivers

The market is majorly driven due to the high prevalence of fungal infections in Kenya.

Approximately 594,660 Kenyan women get more than 4 episodes Candida vulvovaginitis  annually and Tinea capitis infects 9.6% of children in Kenya.

Oral  thrush, Oesophageal  candidiasis, Cryptococcal  meningitis and Pneumocystis pneumonia are common opportunistic infection among HIV infected patients.Chronic Pulmonary Aspergillosis is prevalent following Tuberculosis infection.

Kenya has approximately 40% of its population in the age group 0-15 years. This age group is highly susceptible to fungal infections like Tinea capitis.

Increase in the number of hospital-acquired infections is expected to augment growth of antifungal drug market.

In most parts of the coast, relative humidity is high year-round which presents ideal temperature of the fungi to thrive and grow causing high incidence of fungal infections in coastal regions.

However, increased resistance has been observed among the Candida and Aspergillus species towards antifungal drugs is restraining the growth of antifungal market.


1. Kenya Antifungal Drug Market Overview………………………………………………
A. Market Size
2. Market Growth Drivers…………………………………………………………………
A. High Burden of Fungal Infections Among Children in Kenya
B. Increasing Youth in Kenya who are Susceptible to Fungal Infections
C. High Incidence of Fungal Infections in Coastal Regions of the Country
3. Major fungal Infections……………………………………………………………….
A. Tinea Capitis
B. Oral Candidiasis
C. Oesophageal Candidiasis
D. Vaginal Candidiasis
E. Chronic Pulmonary Aspergillosis
F. Cryptococcal Meningitis
G. Pneumocystis Pneumonia
H. Fungal Keratitis
4. Antifungal Drug Market Segmentation…………………………………………………
A. Drug Class
I. Echinocandins
II. Azoles
III. Polyenes
IV. Allylamines
V. Others
B. Route of Administration
I. Oral
II. Topical
III. Parenteral
C. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
IV. Others
5. Antifungal Major Drugs Market Share…………………………………………….
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape……………………………………………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………
A. GlaxoSmithKline Company overview, Product & Services, Strategies & Financials
B. Sanofi (SA) Company overview, Product & Services, Strategies & Financials
C. Glenmark Pharmaceutical Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………….
A. New Trends and Development of Antifungal drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

The Anti-fungal Drugs market is segmented by Drug Class into Echinocandins, Azoles, Polyenes, Allylamines, and Other Drug Classes

Azoles drug class dominates the market with leading therapeutic agents such as Noxafil, Diflucan, and Cresemba. The dominance of the market can be attributed to broad-spectrum activity delivered by Azoles. These agents support fungistatic activities by inhibiting fungal enzymes. Azoles are used in the treatment of candidemia, blastomycosis, systemic candidiasis, and ocular fungal infections.

By Distribution Channel:

On the basis of distribution channel, the market for Antifungal drugs can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others.

Retail pharmacy segment holds the dominant share and is projected to high growth rates throughout the forecast period.

By Route of Administration:

On the basis of route of administration, the market can be segmented into Oral, Topical and Parenteral.

Topical segment holds the dominant share in terms of revenue generated.

Major Players

Some of the players in the market are Glenmark Pharmaceuticals, Abbott, Novartis AG,  Merck & Co., Inc., Sanofi-Aventis, Bayer AG, and GlaxoSmithKline Plc.

Glenmark’s top selling antifungal topical preparations include Candid Antifungal Powder and Cream to treat fungal skin Infections like yeast infections, ringworm and vaginal thrush.

Domestic pharmaceutical companies operating in Kenya leading in the antifungal drug market are DAWA Limited, Cosmos Limited, Didy Pharmaceuticals, Beta healthcare and Universal Pharmaceutical Limited.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements